🇺🇸 FDA
Pipeline program

Blood draw for Lp(a)

CTQJ230A12001

Unknown other completed

Quick answer

Blood draw for Lp(a) for Cardiovascular Disease and Lipoprotein(a) is a Unknown program (other) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Novartis Pharmaceuticals
Indication
Cardiovascular Disease and Lipoprotein(a)
Phase
Unknown
Modality
other
Status
completed

Clinical trials